How Hormone Research Is Changing Our Understanding of Recovery and Aging

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Our understanding of hormones has changed quite a bit over the years. Earlier research often depended on long-term observations. Scientists could see that certain things changed as people aged or recovered from different stresses, but explaining exactly why those changes happened was much harder. Today, researchers can look much closer. Advances in laboratory testing have […]

The post How Hormone Research Is Changing Our Understanding of Recovery and Aging appeared first on Medical News Bulletin.

Building a Career in Social Work: Skills, Roles, and Education

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

A career in social work can be rewarding in many ways. A social worker helps communities, families and individuals access helpful resources that may improve their health and life in general. But the kind of impact you make as a social worker and the responsibilities you carry depend on the industry you’re working in. Industries […]

The post Building a Career in Social Work: Skills, Roles, and Education appeared first on Medical News Bulletin.

How GHB rehab helps people safely recover from GHB addiction

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

How GHB rehabilitation can assist individuals to safely recuperate from GHB dependency. GHB rehab programs can make a big difference between attempting to relapse off GHB on your own and a safer recovery plan led by individuals whose education involves how GHB affects the brain and body. Often times, people don’t realize that an occasional […]

The post How GHB rehab helps people safely recover from GHB addiction appeared first on Medical News Bulletin.

Pickleball players can benefit from routine eye exams

PHOENIX — A standard eye exam is sufficient to make an impact on the visual performance of pickleball players, according to a speaker at Optometry’s Meeting.
“Either you are a pickleball athlete, you know someone who’s a pickleball athlete, or they know someone who’s a pickleball athlete,” Matthew Roe, OD, FAAO, FCOVD, FOVDR, associate professor at Arizona College of Optometry at Midwestern University, said. “It is one of the most popular sports nowadays.”
{{VIDEO}}
“The visual system is one of those things that most athletes never get evaluated. ...[Yet] when you are in a high stress situation,

Trump administration cancels ACA coverage for 760,000, citing fraud

CMS said it is taking action to combat alleged fraud in the Affordable Care Act program.
One expert told Healio the move could further strain the nation’s healthcare system.
In a press conference Tuesday, Vice President JD Vance and CMS administrator Mehmet Oz, MD, announced CMS is canceling 315,000 “unauthorized enrollments,” removing coverage for more than 760,000 people believed to be fraudulently enrolled in the ACA.
“We are announcing $2.2 billion in American taxpayer money that we’re saving by doing this amazing common sense and what should have been an obvious thing: We’re actually making

EGFR variant raises lung cancer risk 60-fold in never smokers

A single inherited EGFR mutation may increase lung cancer risk more than 60 times among individuals who never smoked.
An evaluation of more than 3 million people showed the EGFR T790M variant increased risk for lung cancer 25 times overall, with a substantially larger impact on patients who reported never smoking cigarettes.
The variant had no association with any other malignancy.
“We expected a strong effect, but certainly not as strong as this,” Jaclyn LoPiccolo, MD, PhD, attending physician and lung cancer researcher at the Lowe Center for Thoracic Oncology and Center for Cancer Genetics and

Misleading claims about Alzheimer’s blood test spread online

Social media posts about blood tests meant to aid in the diagnosis of Alzheimer’s disease often leave out critical information, and many come from accounts with a financial interest, according to researchers.
More than one-third of posts portrayed the tests as a useful screening tool for asymptomatic people, which conflicts with current guidelines, said Jenna Smith, PhD, a Helen & Robert Ellis postdoctoral research fellow with the University of Sydney.
“The chance of developing dementia is concerning — rightly so. But this misleading information risks convincing healthy people to seek out a

Address diurnal refractive shift in post-RK eyes

Radial keratotomy was a popular refractive procedure in the late 20th century, offering millions of patients a large degree of spectacle freedom.
Decades later, these patients develop cataracts and progressive hyperopia as the cornea continues to flatten. In addition, these deep corneal stromal incisions can cause diurnal fluctuations as the corneal architecture and power can waver daily. When these patients present to our clinic for cataract surgery, we can address the lens opacity, the refractive error and the diurnal fluctuations at the same time.
Patients report a predictable corneal

‘More inclusive research’ needed to reduce Black hair health disparities

Biological, clinical and social determinants contribute to disproportionate hair health disorders and healthcare barriers among people of African descent, according to a study.
According to Lenique K. Huggins, BS, a medical student at the Yale School of Medicine and a co-author of the study, hair health disparities among people of African descent arise from a combination of interconnected factors in the workplace, the clinic and everyday life.
“For example, hair discrimination can create pressure to chemically straighten or otherwise modify curly-textured hair, which can not only increase

FDA OKs drug-eluting balloon for coronary in-stent restenosis

The FDA approved a next-generation sirolimus-eluting balloon for the treatment of coronary in-stent restenosis, Cordis announced.
The drug-eluting balloon (Selution SLR, Cordis) is the first sirolimus-eluting balloon to be approved in the U.S. and is designed to provide sustained limus release for up to 90 days without requiring a permanent implant, according to a company press release. As Healio previously reported, in 2024, the FDA approved a paclitaxel-coated balloon (Agent, Boston Scientific) to treat coronary in-stent restenosis.
Approval of the sirolimus-eluting balloon was based on the